Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

Last Updated: 2025-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

811 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-25

Study Completion Date

2029-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Part 1 and Part 2 of the study, participants in the study will either receive elranatamab (arm A and C) as an injection under the skin at the study clinic or lenalidomide orally once daily at home (arm B). Participation in the study will be approximately five years

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Myeloma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Elranatamab BCMA Multiple Myeloma Newly diagnosed Targeted T-cell MagnetisMM MM7 Phase 3 B-cell Maturation Antigen monoclonal antibody Stem cell transplant Autologous stem cell transplant (ASCT) Hematologic disease Minimum residual disease Lenalidomide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A - Part 1

Elranatamab

Group Type EXPERIMENTAL

Elranatamab

Intervention Type DRUG

BCMA-CD3 bispecific antibody

Arm B - Part 1

Lenalidomide

Group Type ACTIVE_COMPARATOR

Lenalidomide

Intervention Type DRUG

Immunomodulatory drug

Arm B - Part 2

Lenalidomide

Group Type ACTIVE_COMPARATOR

Lenalidomide

Intervention Type DRUG

Immunomodulatory drug

Arm C - Part 2

Elranatamab

Group Type EXPERIMENTAL

Elranatamab

Intervention Type DRUG

BCMA-CD3 bispecific antibody

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Elranatamab

BCMA-CD3 bispecific antibody

Intervention Type DRUG

Lenalidomide

Immunomodulatory drug

Intervention Type DRUG

Lenalidomide

Immunomodulatory drug

Intervention Type DRUG

Elranatamab

BCMA-CD3 bispecific antibody

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of MM as defined according to IMWG criteria (Rajkumar, 2014) with measurable disease at diagnosis
* Part 1 patients must be MRD positive, Part 2 patients can be MRD negative or MRD positive
* History of induction therapy for newly diagnosed MM, followed by high dose therapy and autologous stem cell transplant. Randomization must occur within 120 days from the stem cell transplant. For participants who receive consolidation therapy after ASCT, randomization must occur within 60 days of consolidation and within 7 months from ASCT.
* Partial Response or better according to IMWG criteria at the time of randomization
* Must have an archival bone marrow aspirate sample(s) to identify the dominant malignant (index) clone by central laboratory NGS test (ClonoSEQ assay) that is used to track MRD status. This sample should preferably be collected before induction treatment (eg, at diagnosis) or before transplant.
* ECOG performance status ≤1
* Resolved acute effects of any prior therapy to baseline severity or CTCAE Grade ≤ 1
* Not pregnant and willing to use contraception

Exclusion Criteria

* Plasma cell leukemia
* Amyloidosis, Waldenström's macroglobulinemia
* POEMS syndrome
* Known active CNS involvement or clinical signs of myelomatous meningeal involvement
* Previous MM maintenance treatment
* Prior treatment with BCMA targeted therapy
* Any other active malignancy within 3 years prior to enrollment, except for adequately treated basal cell or squamous cell skin cancer, or carcinoma in situ
* Active, uncontrolled bacterial, fungal, or viral infection, including (but not limited to) HBV, HCV, and known HIV or AIDS-related illness
* Previous administration with an investigational drug or vaccine within 30 days (or as determined by the local requirement) or 5 half-lives preceding the first dose of study intervention used in this study (whichever is longer)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Banner Gateway Medical Center

Gilbert, Arizona, United States

Site Status

Banner Gateway Medical Pavilion

Gilbert, Arizona, United States

Site Status

Banner MD Anderson Cancer Center

Gilbert, Arizona, United States

Site Status

Ronald Reagan UCLA Medical Center

Los Angeles, California, United States

Site Status

UCLA Department of Medicine - Hematology/Oncology

Los Angeles, California, United States

Site Status

UCLA Hematology/Oncology

Los Angeles, California, United States

Site Status

UCLA Hematology/Oncology - Santa Monica

Los Angeles, California, United States

Site Status

Santa Monica UCLA Medical Center & Orthopaedic Hospital

Santa Monica, California, United States

Site Status

Georgetown University Medical Center

Washington D.C., District of Columbia, United States

Site Status

Miami Cancer Institute at Baptist Health, Inc.

Miami, Florida, United States

Site Status

Winship Cancer Institute, Emory University

Atlanta, Georgia, United States

Site Status

Loyola University Chicago

Maywood, Illinois, United States

Site Status

Ascentist Doctor Hospital

Leawood, Kansas, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

American Oncology Partners, P.A. Dba MidAmerica Cancer Care

Kansas City, Missouri, United States

Site Status

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

WMCHealth Advanced Physician Services

Hawthorne, New York, United States

Site Status

Westchester Medical Center

Valhalla, New York, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

OhioHealth Arthur G.H. Bing, MD, Cancer Center

Columbus, Ohio, United States

Site Status

OhioHealth Research Institute

Columbus, Ohio, United States

Site Status

OhioHealth Riverside Methodist Hospital

Columbus, Ohio, United States

Site Status

Baylor University Medical Center

Dallas, Texas, United States

Site Status

Baylor Scott & White Medical Center - Temple

Temple, Texas, United States

Site Status

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

Site Status

Shoalhaven District Memorial Hospital

Nowra, New South Wales, Australia

Site Status

Westmead Hospital

Westmead, New South Wales, Australia

Site Status

Wollongong Hospital

Wollongong, New South Wales, Australia

Site Status

Pindara Private Hospital

Benowa, Queensland, Australia

Site Status

QScan Radiology Clinics

Clayfield, Queensland, Australia

Site Status

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

Epworth Healthcare

East Melbourne, Victoria, Australia

Site Status

Precision Haematology

East Melbourne, Victoria, Australia

Site Status

St Vincent's Hospital (Melbourne)

Fitzroy, Victoria, Australia

Site Status

Slade Pharmacy

Richmond, , Australia

Site Status

Medizinische Universität Wien

Vienna, Vienna, Austria

Site Status

Medizinische Universität Wien

Vienna, , Austria

Site Status

Hanusch-Krankenhaus

Vienna, , Austria

Site Status

Institut Jules Bordet

Anderlecht, Bruxelles-capitale, Région de, Belgium

Site Status

Grand Hôpital de Charleroi

Charleroi, Hainaut, Belgium

Site Status

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi

Yvoir, Namur, Belgium

Site Status

UZ Gent

Ghent, Oost-vlaanderen, Belgium

Site Status

ZNA Middelheim

Antwerp, , Belgium

Site Status

Zna Cadix

Antwerp, , Belgium

Site Status

UZ Brussel

Brussels, , Belgium

Site Status

Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador

Salvador, Estado de Bahia, Brazil

Site Status

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Centro de Pesquisa Clínica - Área Administrativa

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Mae de Deus

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Amaral Carvalho

Jaú, São Paulo, Brazil

Site Status

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP)

Ribeirão Preto, São Paulo, Brazil

Site Status

BP - A Beneficencia Portuguesa de São Paulo

São Paulo, São Paulo, Brazil

Site Status

Clínica Médica São Germano LTDA

SP, São Paulo, Brazil

Site Status

Fundação Doutor Amaral Carvalho

Jaú, , Brazil

Site Status

Américas Medical City

Rio de Janeiro, , Brazil

Site Status

Instituto de Educação, Pesquisa e Gestão em Saúde

Rio de Janeiro, , Brazil

Site Status

ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis

São Paulo, , Brazil

Site Status

HU UNIFESP / SPDM - Hospital São Paulo

São Paulo, , Brazil

Site Status

Universidade Federal de Sao Paulo

São Paulo, , Brazil

Site Status

Hospital Japonês Santa Cruz

São Paulo, , Brazil

Site Status

Clínica Médica São Germano S/S Ltda

São Paulo, , Brazil

Site Status

Arthur J.E. Child Comprehensive Cancer Centre

Calgary, Alberta, Canada

Site Status

Dr. Everett Chalmers Regional Hospital

Fredericton, New Brunswick, Canada

Site Status

Saint John Regional Hospital

Saint John, New Brunswick, Canada

Site Status

Hamilton Health Sciences Corporation

Hamilton, Ontario, Canada

Site Status

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Site Status

Windsor Regional Hospital Cancer Program

Windsor, Ontario, Canada

Site Status

Centre Integre Universitaire de la Santé et de Services Sociaux de l'Est-de-l'ile-de-Montreal,

Montreal, Quebec, Canada

Site Status

McGill University Health Centre

Montreal, Quebec, Canada

Site Status

Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎ

Montreal, Quebec, Canada

Site Status

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

Site Status

Institute of hematology&blood disease hospital

Tianjin, Tianjin Municipality, China

Site Status

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Site Status

Fakultní nemocnice Brno Bohunice

Brno, Brno-město, Czechia

Site Status

Fakultni nemocnice Hradec Kralove

Hradec Králové, Hradec Králové, Czechia

Site Status

Fakultni nemocnice Ostrava

Ostrava, Moravskoslezský kraj, Czechia

Site Status

Fakultni nemocnice Olomouc

Olomouc, , Czechia

Site Status

Vseobecna fakultni nemocnice v Praze

Prague, , Czechia

Site Status

Oulun yliopistollinen sairaala

Oulu, North Ostrobothnia, Finland

Site Status

Turku University Hospital

Turku, Southwest Finland, Finland

Site Status

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)

Helsinki, Uusimaa, Finland

Site Status

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE

Toulouse, Haute-garonne, France

Site Status

Pitie Salpetriere University Hospital

Paris, ORNE, France

Site Status

Gustave Roussy

Villejuif, Val-de-marne, France

Site Status

Centre Hospitalier Universitaire de Poitiers

Poitiers, Vienne, France

Site Status

Chu Grenoble Alpes

La Tronche, , France

Site Status

Hopital Claude Huriez - CHU de Lille

Lille, , France

Site Status

Hôpital Saint Antoine

Paris, , France

Site Status

Hopital Lyon Sud

Pierre-Bénite, , France

Site Status

Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau

Tours, , France

Site Status

Universitätsklinikum Würzburg

Würzburg, Bavaria, Germany

Site Status

Universitätsmedizin Johannes Gutenberg Universität Mainz

Mainz, Rhineland-Palatinate, Germany

Site Status

Universitätsklinikum Leipzig

Leipzig, Saxony, Germany

Site Status

Universitaetsklinikum Schleswig-Holstein Campus Kiel

Kiel, Schleswig-Holstein, Germany

Site Status

Charite Universitätsmedizin Berlin Campus Benjamin Franklin

Berlin, , Germany

Site Status

Klinikum Chemnitz gGMbH

Chemnitz, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Klinikum rechts der Isar der Technischen Universität München

München, , Germany

Site Status

Alexandra General Hospital of Athens

Athens, Attikí, Greece

Site Status

Theageneio Cancer Hospital of Thessaloniki

Thessaloniki, Kentrikí Makedonía, Greece

Site Status

University Hospital of Ioannina

Ioannina, Ípeiros, Greece

Site Status

Somogy Megyei Kaposi Mór Oktató Kórház

Kaposvár, Somogy County, Hungary

Site Status

Semmelweis University

Budapest, , Hungary

Site Status

Dél-Pesti Centrumkórház

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház, Jósa András Oktatókórház

Nyíregyháza, , Hungary

Site Status

Artemis hospital

Gurugram, Haryana, India

Site Status

Medanta-The Medicity

Gurugram, Haryana, India

Site Status

Fortis Memorial Research Institute

Gurugram, Haryana, India

Site Status

Himalayan Institute Hospital Trust University

Dehradun, Uttarakhand, India

Site Status

Tata Medical Center

Kolkata, West Bengal, India

Site Status

Rajiv Gandhi Cancer Institute And Research Centre

Delhi, , India

Site Status

Rabin Medical Center

Petah Tikva, Central District, Israel

Site Status

Sheba Medical Center

Ramat Gan, Central District, Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, Jerusalem, Israel

Site Status

Hadassah Medical Center

Jerusalem, Jerusalem, Israel

Site Status

Hadassah Mount Scopus Medical Center

Jerusalem, Jerusalem, Israel

Site Status

Rambam Health Care Campus

Haifa, Northern District, Israel

Site Status

Soroka Medical Center

Beersheba, Southern District, Israel

Site Status

Tel-Aviv Sourasky Medical Center Dana-Dwek Children's Hospital

Tel Aviv, TELL ABĪB, Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"

Meldola, Emilia-Romagna, Italy

Site Status

Fondazione Policlinico Universitario Agostino Gemelli

Rome, Lazio, Italy

Site Status

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Milan, Lombardy, Italy

Site Status

Policlinico "G. Rodolico"

Catania, Sicily, Italy

Site Status

Azienda Ospedaliero Universitaria Senese

Siena, Tuscany, Italy

Site Status

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi

Ancona, , Italy

Site Status

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola

Bologna, , Italy

Site Status

AOU Policlinico Umberto I

Roma, , Italy

Site Status

Nagoya City University Hospital

Nagoya, Aichi-ken, Japan

Site Status

Gunma University Hospital

Maebashi, Gunma, Japan

Site Status

Kobe City Medical Center General Hospital

Kobe, Hyōgo, Japan

Site Status

Iwate Medical University Hospital

Yahaba-cho, Iwate, Japan

Site Status

University Hospital,Kyoto Prefectural University of Medicine

Kyoto, Kyoto, Japan

Site Status

Tohoku University Hospital

Sendai, Miyagi, Japan

Site Status

Hamamatsu University Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Shizuoka Cancer Center

Sunto-gun, Shizuoka, Japan

Site Status

Nippon Medical School Hospital

Bunkyo-ku, Tokyo, Japan

Site Status

Yamagata University Hospital

Yamagata, Yamagata, Japan

Site Status

Kagoshima University Hospital

Kagoshima, , Japan

Site Status

National Hospital Organization Kumamoto Medical Center

Kumamoto, , Japan

Site Status

University Hospital,Kyoto Prefectural University of Medicine

Kyoto, , Japan

Site Status

National Hospital Organization Okayama Medical Center

Okayama, , Japan

Site Status

Osaka Metropolitan University Hospital

Osaka, , Japan

Site Status

Japanese Red Cross Medical Center

Tokyo, , Japan

Site Status

HagaZiekenhuis

The Hague, South Holland, Netherlands

Site Status

Maastricht Universitair Medisch Centrum

Maastricht, , Netherlands

Site Status

Isala

Zwolle, , Netherlands

Site Status

Oslo Universitetssykehus Ullevål

Oslo, , Norway

Site Status

Stavanger Universitetssykehus

Stavanger, , Norway

Site Status

Centrum Medyczne Pratia Poznań

Skórzewo, Greater Poland Voivodeship, Poland

Site Status

Pratia Onkologia Katowice

Katowice, Silesian Voivodeship, Poland

Site Status

Uniwersyteckie Centrum Kliniczne,

Gdansk, , Poland

Site Status

Uniwersytecki Szpital Kliniczny w Poznaniu

Poznan, , Poland

Site Status

Uniwersyteckie Centrum Kliniczne WUM Centralny Szpital Kliniczny

Warsaw, , Poland

Site Status

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy

Warsaw, , Poland

Site Status

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

Wroclaw, , Poland

Site Status

Gachon University Gil Medical Center

Namdong-gu, Incheon-gwangyeoksi [incheon], South Korea

Site Status

Chonnam National University Hwasun Hospital

Hwasun Gun, Jeonranamdo, South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam, Kyǒnggi-do, South Korea

Site Status

Pusan National University Hospital

Busan, Pusan-kwangyǒkshi, South Korea

Site Status

Seoul National University Hospital

Seoul, Seoul-teukbyeolsi [seoul], South Korea

Site Status

Samsung Medical Center

Seoul, Seoul-teukbyeolsi [seoul], South Korea

Site Status

The Catholic Univ. of Korea Seoul St. Mary's Hospital(Seoul St. Mary's Hospital)

Seoul, Seoul-teukbyeolsi [seoul], South Korea

Site Status

The Catholic Univ. of Korea Seoul St. Mary's Hospital

Seoul, Seoul-teukbyeolsi [seoul], South Korea

Site Status

Kyungpook National University

Daegu, Taegu-kwangyǒkshi, South Korea

Site Status

Kyungpook National University Hospital

Junggu, Taegu-kwangyǒkshi, South Korea

Site Status

Complejo Hospitalario Universitario de Santiago

Santiago de Compostela, A Coruna, Spain

Site Status

Hospital Universitari Vall d'Hebron

Barcelona, Barcelona [barcelona], Spain

Site Status

Institut Català d'Oncologia - L'Hospitalet

L'Hospitalet Del Llobregat, Barcelona [barcelona], Spain

Site Status

Hospital Universitari Mutua Terrassa

Terrassa, Barcelona [barcelona], Spain

Site Status

Institut Catala d' Oncologia. Hospital Germans Trias i Pujol

Badalona, Barcelona, Spain

Site Status

Hospital Universitari Mutua Terrassa

Terrassa, Barcelona, Spain

Site Status

Hospital Universitario de Salamanca

Salamanca, Castille and León, Spain

Site Status

Hospital Clínic de Barcelona

Barcelona, Catalunya [cataluña], Spain

Site Status

Hospital Universitario Quironsalud Madrid

Pozuelo de Alarcón, Madrid, Spain

Site Status

Clinica Universidad de Navarra

Madrid, Madrid, Comunidad de, Spain

Site Status

Hospital Universitario La Paz

Madrid, Madrid, Comunidad de, Spain

Site Status

Hospital San Pedro de Alcántara

Cáceres, , Spain

Site Status

Institut Catala Oncologia - Hospital Universitari de Girona Dr Josep Trueta

Girona, , Spain

Site Status

Hospital La Princesa

Madrid, , Spain

Site Status

Hospital General Universitario Gregorio Marañon

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Hospital Universitario HM Sanchinarro

Madrid, , Spain

Site Status

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca

Salamanca, , Spain

Site Status

Hospital Universitari i Politecnic La Fe

Valencia, , Spain

Site Status

Helsingborgs Lasarett

Helsingborg, Skåne LÄN [se-12], Sweden

Site Status

Karolinska Universitetssjukhuset Huddinge

Stockholm, Stockholms LÄN [se-01], Sweden

Site Status

Södra Älvsborgs Sjukhus Borås

Borås, Västra Götalands LÄN [se-14], Sweden

Site Status

Falu Lasarett

Falun, , Sweden

Site Status

Universitetssjukhuset Örebro

Örebro, Örebro LÄN [se-18], Sweden

Site Status

Universitetssjukhuset i Linköping

Linköping, Östergötlands LÄN [se-05], Sweden

Site Status

CHUV (centre hospitalier universitaire vaudois)

Lausanne, Canton of Vaud, Switzerland

Site Status

UniversitätsSpital Zürich

Zurich, Zürich (DE), Switzerland

Site Status

Kantonsspital Baden

Baden, , Switzerland

Site Status

Inselspital Bern

Bern, , Switzerland

Site Status

Kantonsspital Winterthur

Winterthur, , Switzerland

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Chang Gung Medical Foundation-Linkou Branch

Taoyuan District, , Taiwan

Site Status

Medipol Mega Universite Hastanesi

Istanbul, İ̇stanbul, Turkey (Türkiye)

Site Status

Sisli Florence Nightingale Hastanesi

Istanbul, İ̇stanbul, Turkey (Türkiye)

Site Status

Ege Universitesi Hastanesi

Izmir, İ̇zmir, Turkey (Türkiye)

Site Status

Dokuz Eylul Universitesi Hastanesi

Izmir, İ̇zmir, Turkey (Türkiye)

Site Status

Ankara University Health Practice and Research Hospitals

Ankara, , Turkey (Türkiye)

Site Status

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Aydın Adnan Menderes Universitesi Hastanesi

Aydin, , Turkey (Türkiye)

Site Status

Erciyes Universitesi Tıp Fakultesi Hastaneleri

Kayseri, , Turkey (Türkiye)

Site Status

Özel Anadolu Sağlık Merkezi

Kocaeli, , Turkey (Türkiye)

Site Status

Addenbrooke's Hospital

Cambridge, Cambridgeshire, United Kingdom

Site Status

Queen Elizabeth Hospital Birmingham

Birmingham, England, United Kingdom

Site Status

Belfast City Hospital

Belfast, , United Kingdom

Site Status

The Beatson West of Scotland Cancer Centre

Glasgow, , United Kingdom

Site Status

Royal Berkshire Hospital

Reading, , United Kingdom

Site Status

New Cross Hospital

Wolverhampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Brazil Canada China Czechia Finland France Germany Greece Hungary India Israel Italy Japan Netherlands Norway Poland South Korea Spain Sweden Switzerland Taiwan Turkey (Türkiye) United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

https://pmiform.com/clinical-trial-info-request?StudyID=C1071007

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MagnetisMM-7

Identifier Type: OTHER

Identifier Source: secondary_id

2023-508897-27-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

C1071007

Identifier Type: -

Identifier Source: org_study_id